Interview with G. Caleb Alexander, MD, MS, and Hemalkumar B. Mehta, MS, PhD, authors of Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US. Hosted by Jamie Coleman, MD. Related Content: <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2025.3089?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2025.3099?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">The GLP-1 Era—What Comes After Bariatric Surgery?</a></li> </ul>

Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists

Interviews with authors of articles from JAMA Surgery. JAMA Surgery is an international peer-reviewed journal that promotes the art and science of surgery by publishing relevant peer-reviewed research to assist the surgeon in optimizing patient care. JAMA Surgery also serves as a forum for the discussion of issues pertinent to surgery, such as the education and training of the surgical workforce, quality improvement, and the ethics and economics of healthcare delivery.